Inversago Pharma Inc
Inversago Pharma Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing innovative treatments for patients suffering from metabolic and fibrotic diseases. The company is at the forefront of developing therapies that target the inhibition of peripheral CB1 receptors to alleviate complications associated with metabolic disorders.
The company's primary program, INV202, is currently undergoing Phase 2 studies for treating diabetes and associated conditions. Inversago Pharma aims to advance its pipeline of CB1 receptor inhibitors to improve the quality of life for patients affected by various metabolic diseases, including type 1 and type 2 diabetes, non-alcoholic fatty liver disease, and fibrotic diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.